Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study

  1. Maerevoet, M.
  2. Zijlstra, J.M.
  3. Follows, G.
  4. Casasnovas, R.-O.
  5. Vermaat, J.S.P.
  6. Kalakonda, N.
  7. Goy, A.
  8. Choquet, S.
  9. Van Den Neste, E.
  10. Hill, B.
  11. Thieblemont, C.
  12. Cavallo, F.
  13. De la Cruz, F.
  14. Kuruvilla, J.
  15. Hamad, N.
  16. Jaeger, U.
  17. Caimi, P.
  18. Gurion, R.
  19. Warzocha, K.
  20. Bakhshi, S.
  21. Sancho, J.-M.
  22. Schuster, M.
  23. Egyed, M.
  24. Offner, F.
  25. Vassilakopoulos, T.P.
  26. Samal, P.
  27. Ku, M.
  28. Ma, X.
  29. Corona, K.
  30. Chamoun, K.
  31. Shah, J.
  32. Shacham, S.
  33. Kauffman, M.G.
  34. Canales, M.
  35. Show all authors +
Journal:
Journal of Hematology and Oncology

ISSN: 1756-8722

Year of publication: 2021

Volume: 14

Issue: 1

Type: Letter

DOI: 10.1186/S13045-021-01122-1 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus